Determination of the Activity of an Experimental Anti-choleric Immunoenterosorbent <i>in Vitro</i> in Dot-immunoanalysis
Introduction. At the rate of World health organization from 1 to 4 million people annually get infected with cholera, and around 143 000 people become a victim of this infection. At this point of seventh pandemic WHO and its partners actively evaluate new methods of treatment and prevention of chole...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2022-05-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/1213 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!